Companion diagnostic developers can use either an investigational device exemption or investigational new drug application as a means to study the assay for FDA approval, a top diagnostics official at CDRH clarified last week.
Industry groups commenting on the agency’s companion diagnostics draft guidance, released in July, have expressed concern that the wording of...